Myosin VI regulates ciliogenesis by promoting the turnover of the centrosomal/satellite protein OFD1-Reference-Cited by-同舟云学术

Myosin VI regulates ciliogenesis by promoting the turnover of the centrosomal/satellite protein OFD1

Published:2021-12-27 Issue: Volume: Page:
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Reports

Author:

Magistrati Elisa¹^ORCID,Maestrini Giorgia¹^ORCID,Niño Carlos A¹^ORCID,Lince‐Faria Mariana²,Beznoussenko Galina¹,Mironov Alexandre¹,Maspero Elena¹^ORCID,Bettencourt‐Dias Mónica²^ORCID,Polo Simona¹³^ORCID

Affiliation:

1. IFOM Fondazione Istituto FIRC di Oncologia Molecolare Milan Italy

2. IGC Instituto Gulbenkian de Ciencia Oeiras Portugal

3. Dipartimento di Oncologia ed Emato‐oncologia Università degli Studi di Milano Milan Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embr.202154160

Reference61 articles.

1. A non-canonical Hedgehog pathway initiates ciliogenesis and autophagy

2. The Primary Cilium as a Complex Signaling Center

3. Correlative Video-Light–Electron Microscopy of Mobile Organelles

4. Clathrin light chain A drives selective myosin VI recruitment to clathrin-coated pits under membrane tension

5. A novel X-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral–facial–digital type I syndrome

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiniBAR/GARRE1 is a dual Rac and Rab effector required for ciliogenesis;Developmental Cell;2023-11

2. A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia;Cell Reports;2023-08

3. MiniBAR/KIAA0355 is a dual Rac and Rab effector required for ciliogenesis;2023-07-24

4. Cytoskeletal networks in primary cilia: Current knowledge and perspectives;Journal of Cellular Physiology;2022-08-24

5. Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity;Frontiers in Oncology;2022-03-11